Home LiteratureArticle Details
PMID: 19841380 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Family history of melanoma and Parkinson disease risk.

Neurology ·Vol. 73 ·No. 16 ·2009-10-20 ·Pages 1286-91

Gao X, Simon KC, Han J, Schwarzschild MA, Ascherio A

Abstract

Co-occurrence of Parkinson disease (PD) and melanoma has been reported in numerous studies. If this was due to common genetic mechanisms, a positive family history of melanoma would be associated with an excessive PD risk, independent of environmental risk factors for PD. We prospectively examined associations between a family history of melanoma and PD among 157,036 men and women free of PD at baseline (1990 for men and 1982 for women) who participated in 2 ongoing US cohorts: the Health Professional Follow-up Study and the Nurses' Health Study. Information on family history of melanoma in parents or siblings was assessed via questionnaire. Relative risks and 95% confidence intervals were estimated using Cox proportional hazards models and pooled using a fixed-effects model. During 14-20 years follow-up, we identified 616 incident PD cases. A family history of melanoma in a first-degree relative was associated with a higher risk of PD (multivariate relative risk = 1.85; 95% confidence interval: 1.2, 2.8; p = 0.004), after adjusting for smoking, ethnicity, caffeine intake, and other covariates. In contrast, we did not observe significant associations between a family history of colorectal, lung, prostate, or breast cancer and PD risk. Interactions between melanoma family history and age, smoking, or caffeine intake were not significant and subgroup analyses according to these factors generated similar results. Our findings support the notion that melanoma and Parkinson disease (PD) share common genetic components. The genetic determinants of melanoma could therefore be explored as susceptibility candidate genes for PD.

MeSH Terms
Family Female Follow-Up Studies Genetic Predisposition to Disease Humans Male Melanoma/epidemiology,genetics Middle Aged Multivariate Analysis Parkinson Disease/epidemiology,genetics Proportional Hazards Models Prospective Studies Risk Risk Factors Surveys and Questionnaires
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Gao X
Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. xiang.gao@channing.harvard.edu
Simon K C
Han J
Schwarzschild M A
Ascherio A
References (33)
33 references, click to expand
  1. Malignant melanoma and levodopa: is there a relationship? Two new cases and a review of the literature.
    J Am Acad Dermatol. 1997 Aug;37(2 Pt 2):332-6 PMID: 9270541
  2. Diet, urate, and Parkinson's disease risk in men.
    Am J Epidemiol. 2008 Apr 1;167(7):831-8 PMID: 18326873
  3. Treatment with levodopa and risk for malignant melanoma.
    Mov Disord. 2007 Jul 15;22(9):1252-7 PMID: 17534943
  4. Meta-analysis of epidemiologic dose-response data.
    Epidemiology. 1993 May;4(3):218-28 PMID: 8512986
  5. Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England.
    BMC Cancer. 2008 Sep 26;8:271 PMID: 18822122
  6. Inhibition of cyclin-dependent kinases is neuroprotective in 1-methyl-4-phenylpyridinium-induced apoptosis in neurons.
    Neuroscience. 2007 Apr 25;146(1):350-65 PMID: 17343987
  7. Expression of cell cycle regulators in human cutaneous malignant melanoma.
    Melanoma Res. 1999 Apr;9(2):148-54 PMID: 10380937
  8. The risk for cutaneous malignant melanoma, melanoma in situ and intraocular malignant melanoma in relation to tobacco use and body mass index.
    Br J Dermatol. 2007 Jan;156(1):99-105 PMID: 17199574
  9. Erectile function and risk of Parkinson's disease.
    Am J Epidemiol. 2007 Dec 15;166(12):1446-50 PMID: 17875583
  10. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors.
    Eur J Cancer. 2005 Sep;41(14):2040-59 PMID: 16125929
  11. Risk and protective factors for Parkinson's disease: a study in Swedish twins.
    Ann Neurol. 2005 Jan;57(1):27-33 PMID: 15521056
  12. Melanocortin 1 receptor variants and skin cancer risk.
    Int J Cancer. 2006 Oct 15;119(8):1976-84 PMID: 16721784
  13. Pigmentation genes link Parkinson's disease to melanoma, opening a window on both etiologies.
    Med Hypotheses. 2009 Mar;72(3):280-4 PMID: 19027242
  14. Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence?
    Parkinsonism Relat Disord. 2003 Aug;9(6):321-7 PMID: 12853231
  15. Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort.
    Cancer Causes Control. 2003 Nov;14(9):847-57 PMID: 14682442
  16. Risk of cutaneous melanoma associated with a family history of the disease. The International Melanoma Analysis Group (IMAGE).
    Int J Cancer. 1995 Aug 9;62(4):377-81 PMID: 7635561
  17. Levodopa and the risk of melanoma.
    Lancet. 2007 Jan 27;369(9558):257-8 PMID: 17258651
  18. Inhibition of CDKs: a strategy for preventing kainic acid-induced apoptosis in neurons.
    Ann N Y Acad Sci. 2003 Dec;1010:671-4 PMID: 15033809
  19. Malignant melanoma in early Parkinson's disease: the DATATOP trial.
    Mov Disord. 2007 Apr 15;22(5):720-2 PMID: 17373726
  20. Risk factors and individual probabilities of melanoma for whites.
    J Clin Oncol. 2005 Apr 20;23(12):2669-75 PMID: 15837981
  21. Malignant melanoma and other types of cancer preceding Parkinson disease.
    Epidemiology. 2006 Sep;17(5):582-7 PMID: 16837822
  22. Levodopa therapy and the risk of malignant melanoma.
    Ann Pharmacother. 2000 Mar;34(3):382-5 PMID: 10917387
  23. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption.
    Int J Epidemiol. 1989 Dec;18(4):858-67 PMID: 2621022
  24. Pooled analysis of tobacco use and risk of Parkinson disease.
    Arch Neurol. 2007 Jul;64(7):990-7 PMID: 17620489
  25. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women.
    Ann Neurol. 2001 Jul;50(1):56-63 PMID: 11456310
  26. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire.
    J Am Diet Assoc. 1993 Jul;93(7):790-6 PMID: 8320406
  27. Comparison of self-reported and database-linked family history of cancer data in a case-control study.
    Am J Epidemiol. 1997 Aug 1;146(3):244-8 PMID: 9247008
  28. Atypical cancer pattern in patients with Parkinson's disease.
    Br J Cancer. 2005 Jan 17;92(1):201-5 PMID: 15583688
  29. Social inequality and incidence of and survival from malignant melanoma in a population-based study in Denmark, 1994-2003.
    Eur J Cancer. 2008 Sep;44(14):2043-9 PMID: 18664405
  30. Genetic determinants of hair color and Parkinson's disease risk.
    Ann Neurol. 2009 Jan;65(1):76-82 PMID: 19194882
  31. Increased cancer risk for individuals with a family history of prostate cancer, colorectal cancer, and melanoma and their associated screening recommendations and practices.
    Cancer Causes Control. 2008 Feb;19(1):1-12 PMID: 17906935
  32. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history.
    JAMA. 2004 Sep 22;292(12):1480-9 PMID: 15383520
  33. Multiple primary melanoma following administration of levodopa.
    Arch Pathol. 1972 Jun;93(6):556-61 PMID: 5025039
Article Info
Journal
Neurology
Abbr.
Neurology
ISSN
1526-632X
Published
2009-10-20
Pages
1286-91
Language
English
Region
United States
NLM ID
0401060
PMCID
PMC2764417
Subset
IM
Grants
NINDS NIH HHS · R01 NS048517 · United States
Corrections
CommentIn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com